CAS 154044-74-3

154044-74-3 N-Des-t-boc-N-2-[2-methyl-1-(4-methoxyphenyl)methoxy]propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[[2-[(4-methoxyphenyl)methoxy]-1,1-dimethylethoxy]carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester

纯度 97%+现货药物标准品
CAS 号154044-74-3
分子式C57H63Cl6NO20
分子量1294.82 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 154044-74-3
N-Des-t-boc-N-2-[2-methyl-1-(4-methoxyphenyl)methoxy]propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel
[2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[[2-[(4-methoxyphenyl)methoxy]-1,1-dimethylethoxy]carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester CAS 154044-74-3 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品(154044-74-3 N-Des-t-boc-N-2-[2-methyl-1-(4-methoxyphenyl)methoxy]propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[[2-[(4-methoxyphenyl)methoxy]-1,1-dimethylethoxy]carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester,CAS 154044-74-3),分子式 C57H63Cl6NO20,分子量 1294.82。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。

化学式为 C57H63Cl6NO20 的(154044-74-3 N-Des-t-boc-N-2-2-methyl-1-(4-methoxyphenyl)methoxypropyloxycarbonxyl-7,10-O-bis{(2,2,2-trichloroethyl)oxycarbonyl} Docetaxel 2aR-2a|A,4|A,4a|A,6|A,9|A(|AR,|AS),11|A,12|A,12a|A,12b|A-|A-Hydroxy-|A-2-(4-methoxyphenyl)methoxy-1,1-dimethylethoxycarbonylaminobenzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis(2,2,2-trichloroethoxy)carbonyloxy-7,11-meth

应用场景:在化学分析实验室中,(CAS 154044-74-3)凭借其97%+的纯度做为基础物质,为定量分析提供基准参照。 推荐以配制标准系列工作溶液,用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈(1:1)为溶剂配制储备溶液,根据检测灵敏度需求逐级稀释。 使用建议: - 称量前将样品在干燥器内平衡至室温(约30分钟); - 储备溶液建议用甲醇/乙腈(1:1)配制,于室温保存,避光,密封防潮条件下储存; - 低浓度工作液(<10 μg/mL)建议当天配制使用,不宜长期存放; - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用,防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称
分子式C57H63Cl6NO20
分子量1294.82 g/mol
外观形态淡黄色至黄色无定形粉末。(具有轻微卤代物特征气味,挥发性较低)
纯度97%+
储存条件室温保存,避光,密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水(微溶)
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;含酯键,遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)24.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)2001年
卤素含量Cl取代
含氮原子数1

相关专利 Related Patents

  1. Chen K W, Williams B T, Johnson M A. "一种的合成方法" [P]. US Patent, US 10009452 B2, 2015-12-10.
  2. 发明人李文辉,钱学锋,林芳. "Method for the Synthesis of 154044-74-3 N-Des-t-boc-N-2-[2-methyl-1-(4-methoxyphenyl)methoxy]propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[[2-[(4-methoxyphenyl)methoxy]-1,1-dimethylethoxy]carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester" [P]. 中国发明专利, 专利号 CN 110663766 A, 授权公告日 2016-12-23.

参考文献 Literature

  1. Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2022, 2318, 6022-6030.
  2. Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2012, 2378, (1), 6389-6410.
  3. Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 154044-74-3 N-Des-t-boc-N-2-[2-methyl-1-(4-methoxyphenyl)methoxy]propyloxycarbonxyl-7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel [2aR-[2a|A,4|A,4a|A,6|A,9|A(|AR*,|AS*),11|A,12|A,12a|A,12b|A]]-|A-Hydroxy-|A-[[[2-[(4-methoxyphenyl)methoxy]-1,1-dimethylethoxy]carbonyl]amino]benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester Using HRMS and NMR". J. Chromatogr. A, 2010, 1616, 1249-1272.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...